424 related articles for article (PubMed ID: 20932655)
1. Lung density changes after stereotactic radiotherapy: a quantitative analysis in 50 patients.
Palma DA; van Sörnsen de Koste J; Verbakel WF; Vincent A; Senan S
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):974-8. PubMed ID: 20932655
[TBL] [Abstract][Full Text] [Related]
2. Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors.
Diot Q; Kavanagh B; Schefter T; Gaspar L; Stuhr K; Miften M
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1024-30. PubMed ID: 22583607
[TBL] [Abstract][Full Text] [Related]
3. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Guckenberger M; Klement RJ; Kestin LL; Hope AJ; Belderbos J; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Xiao Y; Grills IS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1074-81. PubMed ID: 23154077
[TBL] [Abstract][Full Text] [Related]
4. SU-E-J-188: Lung CT Density Changes during the Conformal Radiotherapy: A Prediction for Lung Radiation Pneumonitis.
Ma C; Yin Y
Med Phys; 2012 Jun; 39(6Part9):3696. PubMed ID: 28519051
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm.
Takeda A; Sanuki N; Kunieda E; Ohashi T; Oku Y; Takeda T; Shigematsu N; Kubo A
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):442-8. PubMed ID: 18990507
[TBL] [Abstract][Full Text] [Related]
6. Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC).
Navarria P; Ascolese AM; Mancosu P; Alongi F; Clerici E; Tozzi A; Iftode C; Reggiori G; Tomatis S; Infante M; Alloisio M; Testori A; Fogliata A; Cozzi L; Morenghi E; Scorsetti M
Radiother Oncol; 2013 Jun; 107(3):414-8. PubMed ID: 23725859
[TBL] [Abstract][Full Text] [Related]
7. Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy.
Vinogradskiy Y; Diot Q; Kavanagh B; Schefter T; Gaspar L; Miften M
Med Phys; 2013 Aug; 40(8):081712. PubMed ID: 23927309
[TBL] [Abstract][Full Text] [Related]
8. Correlation of Clinical and Dosimetric Parameters With Radiographic Lung Injury Following Stereotactic Body Radiotherapy.
Kishan AU; Wang PC; Sheng K; Yu V; Ruan D; Cao M; Tenn S; Low DA; Lee P
Technol Cancer Res Treat; 2015 Aug; 14(4):411-8. PubMed ID: 25261069
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non‒small-cell lung cancer or lung metastases.
Chi A; Jang SY; Welsh JS; Nguyen NP; Ong E; Gobar L; Komaki R
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):856-62. PubMed ID: 21255942
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of interfractional variation of the centroid position and volume of internal target volume during stereotactic body radiotherapy of lung cancer using cone-beam computed tomography.
Sun Y; Ge H; Cheng S; Yang C; Zhu Q; Li D; Tian Y
J Appl Clin Med Phys; 2016 Mar; 17(2):461-472. PubMed ID: 27074466
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiotherapy using tomotherapy for early-stage non-small cell lung carcinoma: analysis of intrafraction tumour motion.
Boggs DH; Feigenberg S; Walter R; Wissing D; Patel B; Wu T; Rosen L
J Med Imaging Radiat Oncol; 2014 Dec; 58(6):706-13. PubMed ID: 24767098
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer.
Dunlap NE; Yang W; McIntosh A; Sheng K; Benedict SH; Read PW; Larner JM
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1071-7. PubMed ID: 22898383
[TBL] [Abstract][Full Text] [Related]
13. Voxel-by-voxel correlation between radiologically radiation induced lung injury and dose after image-guided, intensity modulated radiotherapy for lung tumors.
Avanzo M; Barbiero S; Trovo M; Bissonnette JP; Jena R; Stancanello J; Pirrone G; Matrone F; Minatel E; Cappelletto C; Furlan C; Jaffray DA; Sartor G
Phys Med; 2017 Oct; 42():150-156. PubMed ID: 29173909
[TBL] [Abstract][Full Text] [Related]
14. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
Allibhai Z; Taremi M; Bezjak A; Brade A; Hope AJ; Sun A; Cho BC
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1064-70. PubMed ID: 24210082
[TBL] [Abstract][Full Text] [Related]
15. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
Guckenberger M; Klement RJ; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N; Flentje M
Radiother Oncol; 2013 Oct; 109(1):13-20. PubMed ID: 24183066
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study.
Guckenberger M; Heilman K; Wulf J; Mueller G; Beckmann G; Flentje M
Radiother Oncol; 2007 Dec; 85(3):435-42. PubMed ID: 18053602
[TBL] [Abstract][Full Text] [Related]
18. Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques.
Palma DA; Senan S; Haasbeek CJ; Verbakel WF; Vincent A; Lagerwaard F
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):506-13. PubMed ID: 20584582
[TBL] [Abstract][Full Text] [Related]
19. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
[TBL] [Abstract][Full Text] [Related]
20. Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.
Burdick MJ; Stephans KL; Reddy CA; Djemil T; Srinivas SM; Videtic GM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1033-9. PubMed ID: 20472359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
